|
1
|
Murray CD, Kamm MA, Bloom SR, Emmanuel AV. Ghrelin for the gastroenterologist: history and potential. Gastroenterology 2003; 125(5), 1492-1502. ISSN: 0016-5085
|
|
2
|
Murray CD, Flynn J, Ratcliffe L, Jacyna M R, Kamm MA, Emmanuel AV. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 2004; 127, 1695-1703. ISSN: 0016-5085
|
|
3
|
Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126: 451-9.
|
|
4
|
Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004; 53: 1813-6.
|
|
5
|
Murray,C.D., Martin,N.M., Patterson,M., Taylor,S.A., Ghatei,M.A., Kamm,M.A., Johnston,C., Bloom,S.R., Emmanuel,A.V. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005; 54, 1693-1698. ISSN: 0017-5749
|
|
6
|
Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, Kamm M, Knight SC, Forbes A. The clinical, microbiological and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease. Gut 2006; 55: 348-55.
|
|
7
|
Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006; 130: 1030-38 (with accompanying editorial).
|
|
8
|
Polymeros D, Bogdanos D, Day R, Arioli D, Vergani D, Forbes A. Cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens in Crohn's disease. Gastroenterology 2006; 131: 85-96 (with accompanying editorial).
|
|
9
|
Papadia C, Sherwood RA, Kalantzis C, Wallis K, Volta U, Fiorini E, Forbes A. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol 2007; 102:1-9. PMID:17459021
|
|
10
|
Blaker JJ, Pratten J, Ready D, Knowles JC, Forbes A, Day RM. Assessment of antimicrobial microspheres as a prospective novel treatment targeted towards the repair of perianal fistulae. Aliment Pharmacol Ther 2008; 28: 614-22. PMID: 18565160.
|
|
11
|
Pironi L, Forbes A, Joly F, Colomb V, Lyszkowska M, Van Gossum A, Baxter J, Thul P, Hébuterne X, Gambarara M, Gottrand F, Moreno Villares JM, Messing B, Goulet O, Staun M. Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up. Gastroenterology 2008; 135: 61-71 (with accompanying editorial and editorial summary).
|
|
12
|
Keshaw H, Georgiou G, Blaker JJ, Forbes A, Knowles JC, Day RM. Assessment of polymer/bioactive glass-composite microporous spheres for tissue regeneration applications. Tissue Eng Part A 2009; 15: 1451-61. PMID: 19061428
|
